HCAT — Health Catalyst, Inc.

Health Catalyst (HCAT) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenue: $70.8 million, exceeding guidance of $68 million to $70 million.
• Technology Revenue: $49.5 million; Professional Services Revenue: $21.3 million.
• Adjusted Gross Margin: 51.5%, up from 49.2% year-over-year; Adjusted Technology Gross Margin: 55.3%.
• Adjusted EBITDA: $9.1 million, surpassing guidance of $7 million to $8 million and up from $6.3 million in Q1 2025.
• Cash Position: Ended the quarter with $108.8 million in cash, reflecting a $13.1 million increase from the previous quarter.

2. Strategic Updates and Business Highlights

• Project NEXUS: A comprehensive restructuring initiative aimed at transforming the operating model, expected to generate $30 million in annual run-rate cost savings.
• New Performance Metric: Introduction of "total bookings" as a key operating metric to better gauge commercial performance.
• Client Migration Strategy: Shifted from a rigid migration timeline to a tailored approach for each client, focusing on retention and success.
• Leadership Changes: New appointments in key roles, including a Chief Marketing Officer and Chief Growth Officer, to enhance market messaging and growth strategies.
• AI Integration: Continued investment in AI capabilities to differentiate solutions and improve client outcomes.

3. Forward Guidance and Outlook

• Full Year 2026 Guidance: Expected total revenue of $260 million to $265 million and adjusted EBITDA of $30 million to $33 million.
• Q2 2026 Guidance: Anticipated total revenue of $68 million to $70 million and adjusted EBITDA of $9 million to $10 million.
• Churn Impact: Projected $30 million in at-risk ARR, with efforts to retain $22 million of this amount through tailored client plans.

4. Bad News, Challenges, or Points of Concern

• Revenue Pressure: Ongoing revenue pressure due to prior migration strategy, leading to increased churn and downsell dynamics.
• Professional Services Decline: Expected continued decline in professional services revenue as the company shifts towards a technology-led model.
• Client Transition Hesitancy: Clients are reluctant to transition from the legacy DAS platform to Ignite, citing significant investment in DAS and the complexity of migration.
• Market Conditions: Health systems are under financial pressure, increasing the scrutiny on ROI for new solutions.

5. Notable Q&A Insights

• Shift in Revenue Mix: Management confirmed that services will shrink as a percentage of total revenue, focusing more on technology-driven opportunities.
• Client Retention Strategy: Detailed plans are in place to mitigate churn, emphasizing personalized support for clients during transitions.
• AI Feedback: Positive initial feedback on Ignite Intelligence, particularly in cost management, with a strong belief that proprietary improvement data will enhance client outcomes.
• Competitive Landscape: Recognition of increased competition in the data infrastructure space, with a focus on leveraging the intelligence layer as a differentiator.

Overall, Health Catalyst reported a solid Q1 2026 with strong financial results, but faces challenges related to client migration and market pressures. The company is actively restructuring to position itself for long-term growth while navigating short-term revenue pressures.